JDD Webinars

Recognizing the Role of The Sebaceous Gland in Acne

By October 6, 2020April 22nd, 2021No Comments

Featured Article

Recognizing The Role of the Sebaceous Gland in Acne

The Role of Androgen Receptors in the Development and Management of Acne Vulgaris

Androgen and androgen receptor (AR) may play important roles in several skin related diseases including androgenetic alopecia and acne vulgaris and recent studies suggest AR and androgens play distinct roles in the skin pathogenesis, and AR seems to be a better target than androgens for the treatment of these skin diseases.

Tune in as Leon H. Kircik, MD and James Q. Del Rosso, DO, FAOCD, FAAD discuss the mechanisms by which androgen/AR regulate sebocyte activity in acne vulgaris, and how suppressing AR function by treating with antiandrogens alone, or in combination with antibiotics (i.e., to reduce bacterial infection) might be a potential therapeutic approach to treat acne more effectively.

The results of this open-label clinical study suggest that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.

Faculty


Leon H. Kircik, MD

Clinical Professor of Dermatology
Indiana University School of Medicine
Mount Sinai Medical Center, New York, NY
Physicians Skin Care, PLLC
Louisville, KY


James Q. Del Rosso, DO, FAOCD, FAAD

Research Director & Principal Investigator
JDR Dermatology Research
Thomas Dermatology
Las Vegas, Nevada

You May Also Like

Impact of Intermittent Fasting, Keto Diet vs Continuous Caloric Restriction on Psoriasis Severity: A Systematic Review and Meta-Analysis Protocol

| Featured Articles, Latest News, Psoriasis | No Comments
Evaluating Dietary Strategies as Adjunctive Interventions in Inflammatory Skin Disease As patients increasingly seek non-pharmacologic interventions to support their psoriasis treatment, interest in dietary modifications has surged. However, clinical guidance…
Journal of Drugs in Dermatology JDD featuring The State of Sunscreens in the US: Caveat Emptor

The State of Sunscreens in the US: Caveat Emptor

| Featured Articles, Latest News, Photoprotection | No Comments
From JDD's Vault: The State of Sunscreens in the US: Caveat Emptor  With the FDA’s groundbreaking June 2026 approval of a new sunscreen ingredient, bemotrizinol (also called BEMT or Tinosorb…
Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Beyond the Skin: Navigating Psoriasis Treatment and Patient Burden.

JDD Re:View With Dr. Beer

| Featured Articles, Latest News, Medical Derm, Psoriasis | No Comments
Beyond the Skin: Navigating Psoriasis Treatment and Patient Burden Management of psoriasis can often involve trialing several medications, extensive patient counseling, and working with insurance companies to get the optimal…

Leave a Reply